Yokohama, Japan

Aya Ohkubo

This inventor holds 5 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Shiseido Company, Limited. Active years: 2002-2014.

USPTO Granted Patents = 5 

% Patents Active = 80.0

 

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2002-2014

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Aya Ohkubo: Innovator in Surface Modification Technologies

Introduction

Aya Ohkubo is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of material science, particularly in the area of surface modification. With a total of 5 patents to her name, Ohkubo is recognized for her innovative approaches that enhance the biocompatibility and hydrophilicity of various materials.

Latest Patents

One of her latest patents involves a method for modifying the surface of materials. This method introduces the phosphorylcholine group onto the surface of a material by treating it with a chemical compound containing an aldehyde derivative. This compound is obtained through the oxidative ring-opening reaction of glycerophosphorylcholine. The invention aims to provide medical materials that exhibit superior biocompatibility and hydrophilicity, making them suitable for various applications in the medical field.

Career Highlights

Aya Ohkubo is currently employed at Shiseido Company, Limited, where she continues to develop innovative solutions in material science. Her work has garnered attention for its potential applications in medical technology and beyond.

Collaborations

Ohkubo has collaborated with notable colleagues such as Osamu Shirota and Taketoshi Kanda. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Aya Ohkubo stands out as a leading inventor in the field of surface modification technologies. Her innovative methods and dedication to enhancing material properties have significant implications for the medical industry and beyond.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…